IHH inks 76m-euro deals with Bulgarian healthcare operators

Indirect unit Acibadem to buy Tokuda Hospital and subsidiaries, merge with City Clinic

Published Thu, Apr 21, 2016 · 09:50 PM

Singapore

IN two concurrent moves that will make IHH Healthcare Berhad the largest private healthcare provider in Bulgaria, its indirect subsidiary has inked two deals - an acquisition and a merger - valued at about 76 million euros (S$115.7 million).

In a filing with the local bourse on Thursday, IHH said its indirect subsidiary, Acibadem Saglik Hizmetleri ve Ticaret AS (Acibadem Holdings), on Wednesday agreed to buy Bulgaria- based Tokuda Hospital and its subsidiaries, as well as merge with City Clinic, another healthcare operator in Bulgaria.

Under the proposed acquisition, Acibadem will fully acquire Tokuda Group for 65 million euros.

At the same time, it will buy close to one-third of the existing stake in City Clinic from the existing operating partners for 10.97 million euros.

The remaining stake in City Clinic will be rolled over into a new combined entity.

Acibadem Group will have a 76.5 per cent stake in the newly created holding company's share capital, while the remaining 23.5 per cent stake will be held by City Clinic operating partners. IHH acquired an indirect 60 per cent equity interest in Acibadem Holdings in 2012.

The two transactions will create one of the leading healthcare institutions in Central and Eastern Europe, IHH said, adding that the combined integrated healthcare group will operate under the name, Acibadem City Clinic.

Pending necessary approvals and satisfaction of certain conditions, the transactions are expected to close within three months, said IHH.

City Clinic, founded in 2010, is an integrated healthcare provider with three hospitals and three outpatient centres in Bulgaria, operating in Sofia, Varna and Burgas.

Tokuda Group is the largest private hospital operator in Bulgaria, running a 52,000 square metre state-of-the-art tertiary hospital with 550 beds, an outpatient medical centre, clinical research centre, pharmacy and an hospice, all located at the same site in Sofia. The hospital was opened in 2006 as the first private one owned by a foreign investor in Bulgaria - a 100 per cent Japanese investment.

Mehmet Ali Aydinlar, chairman and chief executive of Acibadem, said the moves are in line with the subsidiary's strategy of focusing on key emerging markets in Central Eastern Europe and the Balkan region.

He added that "Acibadem views the need in the qualified and high- end technology healthcare services in Bulgaria and therefore realised this valuable transaction".

Tan See Leng, managing director and CEO of IHH, noted that the two deals signify IHH's continued commitment to expand in markets where there is a growing demand for quality healthcare. "With this transaction, we are confident our sustained growth path will continue to create further long term value for our shareholders," he said.

The transactions will increase Acibadem's beds globally to more than 3,500 across 22 hospitals in three countries.